Screener
Madrigal Pharmaceuticals, Inc. MDGL Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (56,308) | (47,202) | (149,031) | (126,513) |
| Interest income | 7,104 | 8,227 | 15,347 | 17,597 |
| Interest expense | (7,940) | (3,264) | (15,759) | (6,561) |
| Other expense, net | (795) | (42) | (2,887) | (42) |
| Net loss | $(57,939) | $(42,281) | $(152,330) | $(115,519) |
| Net loss per common, Series A preferred and Series B preferred share: | ||||
| Basic and diluted net loss per common, Series A preferred, and Series B preferred share | $(1.99) | $(1.50) | $(5.24) | $(4.10) |
| Basic and diluted weighted average number of shares outstanding (Note 13) | 29,145,271 | 28,232,604 | 29,089,148 | 28,159,333 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s other income (expense)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported other income (expense) of -$795K in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s other income (expense) decreased by 1792.9% year-over-year, from -$42K to -$795K.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s other income (expense) has grown at a 14.1% compound annual growth rate (CAGR), from $273K to -$463K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude